207 related articles for article (PubMed ID: 18410454)
1. Prediction of survival using absolute lymphocyte count for newly diagnosed patients with multiple myeloma: a retrospective study.
Ege H; Gertz MA; Markovic SN; Lacy MQ; Dispenzieri A; Hayman SR; Kumar SK; Porrata LF
Br J Haematol; 2008 Jun; 141(6):792-8. PubMed ID: 18410454
[TBL] [Abstract][Full Text] [Related]
2. Higher infused lymphocyte dose predicts higher lymphocyte recovery, which in turn, predicts superior overall survival following autologous hematopoietic stem cell transplantation for multiple myeloma.
Hiwase DK; Hiwase S; Bailey M; Bollard G; Schwarer AP
Biol Blood Marrow Transplant; 2008 Jan; 14(1):116-24. PubMed ID: 18158968
[TBL] [Abstract][Full Text] [Related]
3. Absolute lymphocyte count predicts overall survival in follicular lymphomas.
Siddiqui M; Ristow K; Markovic SN; Witzig TE; Habermann TM; Colgan JP; Inwards DJ; White WL; Ansell SM; Micallef IN; Johnston PB; Call TG; Porrata LF
Br J Haematol; 2006 Sep; 134(6):596-601. PubMed ID: 16889618
[TBL] [Abstract][Full Text] [Related]
4. Absolute lymphocyte count at the time of first relapse predicts survival in patients with diffuse large B-cell lymphoma.
Porrata LF; Ristow K; Habermann TM; Witzig TE; Inwards DJ; Markovic SN
Am J Hematol; 2009 Feb; 84(2):93-7. PubMed ID: 19123458
[TBL] [Abstract][Full Text] [Related]
5. Early lymphocyte recovery predicts longer survival after autologous peripheral blood stem cell transplantation in multiple myeloma.
Kim H; Sohn HJ; Kim S; Lee JS; Kim WK; Suh C
Bone Marrow Transplant; 2006 Jun; 37(11):1037-42. PubMed ID: 16708062
[TBL] [Abstract][Full Text] [Related]
6. Complete remission status before autologous stem cell transplantation is an important prognostic factor in patients with multiple myeloma undergoing upfront single autologous transplantation.
Kim JS; Kim K; Cheong JW; Min YH; Suh C; Kim H; Jo DY; Ryoo HM; Yoon SS; Lee JH;
Biol Blood Marrow Transplant; 2009 Apr; 15(4):463-70. PubMed ID: 19285634
[TBL] [Abstract][Full Text] [Related]
7. Prolonged survival associated with early lymphocyte recovery after autologous hematopoietic stem cell transplantation for patients with metastatic breast cancer.
Porrata LF; Ingle JN; Litzow MR; Geyer S; Markovic SN
Bone Marrow Transplant; 2001 Nov; 28(9):865-71. PubMed ID: 11781647
[TBL] [Abstract][Full Text] [Related]
8. Infused peripheral blood autograft absolute lymphocyte count correlates with day 15 absolute lymphocyte count and clinical outcome after autologous peripheral hematopoietic stem cell transplantation in non-Hodgkin's lymphoma.
Porrata LF; Litzow MR; Inwards DJ; Gastineau DA; Moore SB; Pineda AA; Bundy KL; Padley DJ; Persky D; Ansell SM; Micallef IN; Markovic SN
Bone Marrow Transplant; 2004 Feb; 33(3):291-8. PubMed ID: 14676784
[TBL] [Abstract][Full Text] [Related]
9. Early lymphocyte recovery after autologous stem cell transplantation predicts superior survival in mantle-cell lymphoma.
Joao C; Porrata LF; Inwards DJ; Ansell SM; Micallef IN; Johnston PB; Gastineau DA; Markovic SN
Bone Marrow Transplant; 2006 May; 37(9):865-71. PubMed ID: 16532015
[TBL] [Abstract][Full Text] [Related]
10. Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation for patients with primary systemic amyloidosis.
Porrata LF; Gertz MA; Litzow MR; Lacy MQ; Dispenzieri A; Inwards DJ; Ansell SM; Micallef IN; Gastineau DA; Elliott M; Hogan WJ; Hayman SR; Tefferi A; Markovic SN
Clin Cancer Res; 2005 Feb; 11(3):1210-8. PubMed ID: 15709191
[TBL] [Abstract][Full Text] [Related]
11. Apheresis instrument settings influence infused absolute lymphocyte count affecting survival following autologous peripheral hematopoietic stem cell transplantation in non-Hodgkin's lymphoma: the need to optimize instrument setting and define a lymphocyte collection target.
Katipamula R; Porrata LF; Gastineau DA; Markovic SN; Moore SB; Greiner C; Burgstaler EA; Padley DJ; Winters JL
Bone Marrow Transplant; 2006 May; 37(9):811-7. PubMed ID: 16532018
[TBL] [Abstract][Full Text] [Related]
12. The dose of infused lymphocytes in the autograft directly correlates with clinical outcome after autologous peripheral blood hematopoietic stem cell transplantation in multiple myeloma.
Porrata LF; Gertz MA; Geyer SM; Litzow MR; Gastineau DA; Moore SB; Pineda AA; Bundy KL; Padley DJ; Persky D; Lacy MQ; Dispenzieri A; Snow DS; Markovic SN
Leukemia; 2004 Jun; 18(6):1085-92. PubMed ID: 15042106
[TBL] [Abstract][Full Text] [Related]
13. Clinical value of absolute lymphocyte counts before bortezomib-dexamethasone therapy in relapsed multiple myeloma patients.
Song MK; Chung JS; Joo YD; Lee SM; Lee GW; Lee HS; Kim SH; Yun EY; Seol YM; Kim SG; Shin HJ; Choi YJ; Cho GJ
Acta Haematol; 2010; 124(1):34-9. PubMed ID: 20606414
[TBL] [Abstract][Full Text] [Related]
14. Host immunity affects survival in myelodysplastic syndromes: Independent prognostic value of the absolute lymphocyte count.
Jacobs NL; Holtan SG; Porrata LF; Markovic SN; Tefferi A; Steensma DP
Am J Hematol; 2010 Mar; 85(3):160-3. PubMed ID: 20131304
[TBL] [Abstract][Full Text] [Related]
15. Absolute lymphocyte count at day 29 of treatment is a powerful predictor of outcome in multiple myeloma.
Narwani V; Gabriel J; Boyd K; Chevassut T
Clin Lymphoma Myeloma Leuk; 2015 Apr; 15(4):222-6. PubMed ID: 25468320
[TBL] [Abstract][Full Text] [Related]
16. The role of stem cell mobilization regimen on lymphocyte collection yield in patients with multiple myeloma.
Hiwase DK; Hiwase S; Bailey M; Bollard G; Schwarer AP
Cytotherapy; 2008; 10(5):507-17. PubMed ID: 18608354
[TBL] [Abstract][Full Text] [Related]
17. Absolute lymphocyte count recovery after induction chemotherapy predicts superior survival in acute myelogenous leukemia.
Behl D; Porrata LF; Markovic SN; Letendre L; Pruthi RK; Hook CC; Tefferi A; Elliot MA; Kaufmann SH; Mesa RA; Litzow MR
Leukemia; 2006 Jan; 20(1):29-34. PubMed ID: 16281063
[TBL] [Abstract][Full Text] [Related]
18. Timing of autologous stem cell transplantation from last chemotherapy affects lymphocyte collection and survival in non-Hodgkin lymphoma.
Holtan SG; Porrata LF; Inwards DJ; Ansell SM; Micallef IN; Johnston PB; Litzow MR; Gastineau DA; Markovic SN
Br J Haematol; 2006 Jun; 133(6):628-33. PubMed ID: 16704437
[TBL] [Abstract][Full Text] [Related]
19. Low absolute lymphocyte count is a poor prognostic marker in patients with diffuse large B-cell lymphoma and suggests patients' survival benefit from rituximab.
Oki Y; Yamamoto K; Kato H; Kuwatsuka Y; Taji H; Kagami Y; Morishima Y
Eur J Haematol; 2008 Dec; 81(6):448-53. PubMed ID: 18691256
[TBL] [Abstract][Full Text] [Related]
20. High CD8+ lymphocyte dose in the autograft predicts early absolute lymphocyte count recovery after peripheral hematopoietic stem cell transplantation.
Atta EH; de Azevedo AM; Maiolino A; Coelho CJ; Sarcinelli SM; de Alvarenga Máximo C; Marra VL
Am J Hematol; 2009 Jan; 84(1):21-8. PubMed ID: 19006229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]